シンバイオシス株式会社

List of New Arrivals

Interview with Small and Medium Enterprises Organization (SME)

Our CEO, Mr. Tanaka, was interviewed by the Organization for Small & Medium Enterprises and Regional Innovation, Japan (Organization for Small & Medium Enterprises and Regional Innovation, Japan). Our CEO talks about the present and future of the company, from his own background. About the project, The new gut microbiota transplant treatment using “NanoGAS®︎” water developed by our company is Why are antimicrobials, bowel cleansing, etc. not necessary? We also talk about the effects of “NanoGAS®︎” water on human consumption. Please take a look at the interview article. https://www.smrj.go.jp/incubation/report/2023/bkmqel000000a9is.html      Related Pages Differences from other fecal microbiota transplantsDifferences between conventional gut microbiota transplantation and our gut microbiota transplantation

I would like to take this opportunity to wish you all a glorious New Year.

We would also like to thank you for your support of our institute’s activities during the past year. We would also like to thank you for your support of our study group’s activities during the past year. We will continue to strive for further improvement of our services in the New Year and look forward to your continued support and patronage. We wish you a happy and healthy New Year. We look forward to serving you in the New Year. We will be open for business from January 5 (Thu.). New Year’s Day, 2024 Intestinal Flora Transplant Clinical Research Foundation.

Received the Small and Medium Enterprise Agency Director-General’s Award for the patent for “FMT using nanobubbles.

Following last year’s “Nanobubble Generator,” the Company has received the Small and Medium Enterprise Agency Director-General’s Award for its patent for “FMT using nanobubbles. This invention enables the use of a composition containing intestinal bacteria with nanobubbles to significantly improve the survival rate of intestinal microflora transplantation (hereafter referred to as FMT) compared to conventional FMT, as well as to reduce the burden on the patient for treatment. For more information, click here. Small and Medium Enterprise Award: Nanobubble Solution for Intestinal Microflora and Pharmaceuticals (Patent No. 7104435)   What is the Local Invention Award? Award for Engineers and R&D Developers The Local Invention Awards began in 1921 to honor engineers and R&D personnel who have created outstanding inventions, devices, or designs that have been put to practical use. Last year, 1,364 awards were given nationwide. This is your chance to introduce your invention to society through these awards. (Inventions…

Selected for a grant from the New Energy and Industrial Technology Development Organization (NEDO), a national research and development corporation

We are pleased to announce that we have been selected for a grant from the New Energy and Industrial Technology Development Organization (“NEDO”), a national research and development corporation。 Verification of technologies that inhibit oxidation of wine and sake and prolong the flavor of wine and sake when opened, combined with functional testing and gas chromatography measurements.We would be happy if this is a step forward in the utilization of nanobubble technology, which has been put to practical use, in the industrial field as well. At the social gathering of the 7th Annual Meeting of the Intestinal Flora Transplantation Clinical Research Society held this September, sake brewers cooperated with us and we enjoyed a taste comparison. Starting at the beginning of 2024, functional tests will be conducted by qualified personnel (sommeliers and sake tasters). What is NEDO? It is a part of the “Japanese Small Business Innovation Research (SBIR) System,”…

Wage increase plan for employees

We hereby announce that in the fiscal year 2023 (our fiscal year from December 1, 2009 to November 30, 2023), the average amount of wages received per salary recipient (or researchers participating in the proposed R&D project) will increase by 5% or more compared to the previous year (or the previous year).If, after receiving the grant decision, the announced wage increase is not implemented as planned, we will promptly report it.   July 31, 2023   Shinbiosis Corporation2-1-40-401 Katamachi, Miyakojima-ku, Osaka 534-0025, JapanMikiko Tanaka, President

Patented.

We are pleased to announce that we have been granted a patent for “composition containing biological microorganisms and its manufacturing method,” for which an application was filed by Symbiosis, Inc. Patent Information [Patent No.]Patent No. 7104435 Title of the Invention:“Composition Containing Biological Microorganisms and Method of Making the Same.” [Date patented]July 12, 2022 *Patent Information PlatformPlease refer to the patent number “7104435”     ja_horizon

Received the Director General’s Award from the Small and Medium Enterprise Agency!

We are pleased to announce that the Japan Institute of Invention and Innovation (JIII)has awarded the following prize at the 2022 Local Commendation for Invention at Nanobubble Generator (Patent No. 7028499)was honored with the Small and Medium Enterprise Agency Director-General’s Award. Next year, we’re going for a national award atfor our patent on FMT using nanobubbles! Keep up the good work! http://koueki.jiii.or.jp/…/R4/jusho_kinki/index.html

Investment in the “Osaka Social Problem Solving Fund No. 2

The following investment has been made in the “Osaka Social Problem Solving Fund No. 2” to promote the creation and industrialization of new businesses that will help solve social issues in the prefecture. This fund is a “Social Problem Solving Fund” by Osaka Prefecture, Osaka Shinkin Bank and Future Venture Capital Corporation, which was inspired by the Chairman’s Award received at the Osaka Shinkin Bank’s business contest held in February 2022. We will continue to make every effort to solve your problems. Thank you for your continued support. Purification of proprietary bacterial solution for use in “intestinal flora transplantation Social issues to be solved: Establishment of new medical treatment using “intestinal flora transplantation” for autistic spectrum disorder, ulcerative colitis, renal disease, etc., for which no treatment methods have been established. By using technology that utilizes long-term, stable, and transportable…

Contact Us

Click here for inquiry form

06-6948-5088

Reception hours: 10:00-17:00
[excluding Saturdays, Sundays,and holidays]

Related Sites

Patient website

Website for Healthcare Professionals

お問い合わせフォームはこちら